Source: Annual Congress 2004 - Primary care: challenging pulmonary problems



Rating:

Share or cite this content

Citations should be made in the following way:
N. A. Mironova, T. V. Martynyuk, I. Y. Chazova (Moscow, Russia). Life expectancy and various therapy types in primary pulmonary hypertension. Eur Respir J 2004; 24: Suppl. 48, 3348

Member's Comments

No comment yet.

Related content which might interest you: The assessment of life expectancy of patients with primary pulmonary hypertension (PPH) Source: Eur Respir J 2003; 22: Suppl. 45, 582s Year: 2003 EmPHasis-10 is associated with clinical outcome measures in pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Measurement of quality of life in pulmonary hypertension and its significance Source: Eur Respir J 2006 Oct 01;28(4):808-815 Year: 2006 Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Relationship of quality of life and life expectancy with tolerance to physical exercises and cardio respiratory parameters in patients with pulmonary arterial hypertension Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 Impact of riociguat on health-related quality of life (HRQoL) in patients with pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Quality of life and physical functioning in chronic thromboembolic pulmonary hypertension (CTEPH):  the impact of treatment Source: International Congress 2017 – PAH and CTEPH Year: 2017 The assessment of dependence of life expectancy of patients with primary pulmonary hypertension from various influencing factors Source: Eur Respir J 2005; 26: Suppl. 49, 595s Year: 2005 Quality of life in patients with chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2016; 48: 526-537 Year: 2016 Relation of the novel pulmonary hypertension emPHasis10 quality of life score to markers of disease severity Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 Anxiety and depression are highly prevalent in pulmonary hypertension and might improve with target therapy Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 Quality of life in Russian patients with COPD complicated by pulmonary artery hypertension Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD Year: 2008 Is survival in patients with severe group 3 pulmonary hypertension influenced by targeted therapy? Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 Disease-targeted treatment improves cognitive function in patients with pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 The influence of psycho-social factors in the evolution of pulmonary hypertension patients Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Sildenafil improves health-related quality of life in pulmonary arterial hypertension (PAH) patients Source: Eur Respir J 2005; 26: Suppl. 49, 563s Year: 2005 Comparison of cardiac and pulmonary-specific quality-of-life measures in pulmonary arterial hypertension Source: Eur Respir J 2011; 38: 608-616 Year: 2011 Health-related quality of life and disease progression in pulmonary arterial hypertension patients: a 3-year study Source: ERJ Open Res, 7 (3) 00617-2020; 10.1183/23120541.00617-2020 Year: 2021 Health-related quality of life in patients with pulmonary arterial hypertension Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011 Effects of tadalafil on health-related quality of life in patients with pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary arterial hypertension Year: 2009